Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-11-28
2008-11-18
Fay, Zohreh A (Department: 1612)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
Reexamination Certificate
active
07452871
ABSTRACT:
A modified alginate and/or modified pectin composition and method for preventing and/or treating diseases and/or conditions caused by circulating agents such as poisonous heavy metals, environmental toxins, calcium and cholesterol, is provided. The composition includes a modified alginate having a molecular weight of no more than 40,000 daltons and/or a modified pectin having a molecular weight of no more than 40,000 daltons. The method involves orally or intravenously administering the modified alginate and/or modified pectin composition, alone or with excipient.
REFERENCES:
patent: 5063210 (1991-11-01), Lange et al.
patent: 5141927 (1992-08-01), Krotkiewski
patent: 5283076 (1994-02-01), Kazuyuki et al.
patent: 5324526 (1994-06-01), Iwata
patent: 5434141 (1995-07-01), Schafer et al.
patent: 5597810 (1997-01-01), Hoffman et al.
patent: 09 235 234 (1997-09-01), None
Fredrik Hed et al., “Absorption of charged drugs to oppositely charged polysaccharides—a study of the influence of polysaccharide structure and hydrophobicity of the drug molecules”, on-line at http://www.geocites.com/hotsprings/1851/paper.htm as of at least Nov. 24, 1998.
Kenneth Clare et al.,Algin, Chapter 6, pp. 105-143.
M. Kim et al., “Absorption of Polyethylene Glycol (330-1 122 Da) is Greater in the Jejunum than in the Ileum of Rats”,J. Ethnopharmacol, vol. 54, No. 1, pp. 47-54, Oct. 1996.
Kim, M., “Absorption of Polyethylene Glycol Oligomers (330-112 Da) is Greater in the Jejunum than in the Ileum of Rats”,American Institute of Nutrition, pp. 2172-2178 (1996).
Itoh, H., “Immunological Analysis of Inhibition of Lung Metastases by Fucoidan (GIV-A) prepared from Brown SeaweedSargassum thunbergii”, Anticancer Research, 15, pp. 1937-1948 (1995).
Chida, K. et al., “Antitumor Activity of a Crude Fucoidan Fraction Prepared From the Roots of Kelp (Laminariaspecies)”,Kitasato Arch. of Exp. Med.,60, 1-2, pp. 33-39 (1987).
Kimura et al., “Pharmaceutical Evolution of Ibuprofen Fast-Absorbed Syrup Containing Low Molecular-weight Gelatin”,J. Pharm. Sci.,vol. 81, No. 2, pp. 141-144, Feb. 1992 (Abstract).
Kimura et al.,J. Enthnopharmacol, vol. 54, No. 1, pp. 47-54, 1996 (Abstract).
N.G. Schipper et al., “Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 1: Influence of Molecular Weight and Degree of Acetylation on Drug Transport Across Human Intestinal Epithelial (Caco-2) Cells”,Pharm. Res.,vol. 13, No. 11, pp. 1686-1692, Nov. 1996 (Abstract).
L.R. Schiller et al., “Validation of Polyethylene Glycol 3350 as a Poorly Absorbable Marker for Intestinal Perfusion Studies”,Dig. Dis. Sci.,vol. 42, No. 1, pp. 1-5, Jan. 1997 (Abstract).
T. Lindmark et al., “Absorption Enhancement in Intestinal Epithelial Caco=2 Monolayers by Sodium Captrate: Assessment of Molecular Weight Dependence and Demonstration of Transport Routes”, vol. 5, No. 3, pp. 215-223, 1998 (Abstract).
Sumita Jain et al., “Deletion of algK in Mucoid Pseudomonas Aeruginosa Blocks Alignate Polymer Formation and Results in Uronic Acid Secretion”,J. Bac.,pp. 634-641, Feb. 1998 (Abstract).
Murata Kousaku et al., “Microbial enzymes and their application to pharmaceutical areas”,Department of Food Safety and Utilization, vol. 19, pp. 32-46, Nov. 24, 1998.
EcoNugenics, Inc.
Fay Zohreh A
Kelber Steven B.
LandOfFree
Compositions and methods for treating mammals with modified... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating mammals with modified..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating mammals with modified... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4036372